Abstract
Immunotherapy using subcutaneous injections of recombinant interleukin-2 (IL-2) and recombinant interferon alpha-2a (IFN-α) for advanced hematologic and solid tumors is rapidly developing. We report five patients with Hodgkin's and non-Hodgkin's lymphoma who developed a local cutaneous reaction consisting of inflammatory painful nodules with a central multiloculated vesicle at the site of sc injections of IL-2 and IFN-α immunotherapy following ABMT. This is the first report of a local cutaneous adverse reaction induced by IL-2 and IFN-α immunotherapy following ABMT.
Original language | English |
---|---|
Pages (from-to) | 443-446 |
Number of pages | 4 |
Journal | Bone Marrow Transplantation |
Volume | 11 |
Issue number | 6 |
State | Published - 1 Jan 1993 |
Externally published | Yes |
ASJC Scopus subject areas
- Hematology
- Transplantation